This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Seoul National University, Institute for Basic Science. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,800 
1 out of 99 
Years Active: 2021
Title: Kyoungmi Kim: Innovator in Eye Disease Treatment
Introduction
Kyoungmi Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of eye diseases. His innovative approach utilizes advanced genetic techniques to address critical health issues.
Latest Patents
Kyoungmi Kim holds a patent for a method of treating or preventing eye disease using Cas9 protein and guide RNA. This patent outlines a method for preventing and/or treating eye diseases by employing a Cas9 protein and a guide RNA that targets VEGF-A. Additionally, it includes a ribonucleoprotein that comprises a Cas9 protein and a guide RNA aimed at VEGF-A.
Career Highlights
Throughout his career, Kyoungmi Kim has worked with esteemed institutions such as Seoul National University and the Institute for Basic Science. His work has been pivotal in advancing research in genetic therapies and their applications in ophthalmology.
Collaborations
Kyoungmi Kim has collaborated with notable colleagues, including Jin-Soo Kim and Jeong Hun Kim. Their joint efforts have contributed to the development of innovative solutions in the medical field.
Conclusion
Kyoungmi Kim's work exemplifies the intersection of innovation and healthcare, showcasing how genetic engineering can lead to breakthroughs in treating eye diseases. His contributions continue to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile